Medovate and its Saudi Arabia based distributor AKSIA Healthcare have announced they have secured SFDA (Saudi Food and Drug Authority) Approval for the SAFIRA (SAFer Injection for Regional Anaesthesia) technology.
UK-based Medovate, a medical device development company, has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIRA (SAFer Injection for Regional Anaesthesia) product range in Saudi Arabia, the UAE and Bahrain.
UK-based Medovate has announced an agreement with AKSIA Healthcare FZC to distribute its SAFIR (SAFer Injection for Regional Anesthesia) product range in Saudi Arabia, the UAE and Bahrain.
UK-based Medovate, a dynamic medical device development firm, has reached a deal with Aksia Healthcare to distribute its Safira (SAFer Injection for Regional Anaesthesia) product range in Saudi Arabia, the UAE and Bahrain.